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Rabies remains a major public health concern in many developing countries. The precise
neuropathogenesis of rabies is unknown, though it is hypothesized to be due to neuronal
death or dysfunction. Mice that received intranasal inoculation of an attenuated rabies
virus (RABV) strain HEP-Flury exhibited subtle clinical signs, and eventually recovered,
which is different from the fatal encephalitis caused by the virulent RABV strain CVS-11.
To understand the neuropathogenesis of rabies and the mechanisms of viral clearance,
we applied RNA sequencing (RNA-Seq) to compare the brain transcriptomes of normal
mice vs. HEP-Flury or CVS-11 intranasally inoculated mice. Our results revealed that
both RABV strains altered positively and negatively the expression levels of many host
genes, including genes associated with innate and adaptive immunity, inflammation and
cell death. It is found that HEP-Flury infection can activate the innate immunity earlier
through the RIG-I/MDA-5 signaling, and the innate immunity pre-activated by HEP-Flury
or Newcastle disease virus (NDV) infection can effectively prevent the CVS-11 to invade
central nervous system (CNS), but fails to clear the CVS-11 after its entry into the CNS.
In addition, following CVS-11 infection, genes implicated in cell adhesion, blood vessel
morphogenesis and coagulation were mainly up-regulated, while the genes involved
in synaptic transmission and ion transport were significantly down-regulated. On the
other hand, several genes involved in the MHC class II-mediated antigen presentation
pathway were activated to a greater extent after the HEP-Flury infection as compared
with the CVS-11 infection suggesting that the collaboration of CD4+ T cells and MHC
class II-mediated antigen presentation is critical for the clearance of attenuated RABV
from the CNS. The differentially regulated genes reported here are likely to include
potential therapeutic targets for expanding the post-exposure treatment window for
RABV infection.
Keywords: rabies virus, transcriptome, pathogenic and attenuated strains, innate immunity, pathogenesis, MHC
class II
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INTRODUCTION
Rabies is an acute as well as progressive encephalomyelitis caused
by a neurotropic virus known as rabies virus (RABV), which
is a non-segmented negative-stranded RNA virus in the genus
Lyssavirus, family Rhabdoviridae (Schnell et al., 2010). Regardless
of the viral variants found throughout the world, all lyssaviruses
can cause rabies, resulting in the post-exposure prophylaxis
(PEP) in tens of millions of humans, and more than 60,000
human deaths each year (Fooks et al., 2014). The RABV enters
the nervous system through the neuromuscular junctions or
nerve spindles (Lafon, 2005). In the early stages of infection,
while RABV travels through peripheral nerve axons to the central
nervous system (CNS), there is no clear clinical evidence of the
infection. The definitive signs and symptoms of the disease do
not appear until the virus reaches the CNS, when a wide range of
non-specific physiological, as well as more pathognomonic signs
begin to develop (Lafon, 2011).
During its migration to the CNS through the nerves, RABV
has to deal with the first line of cellular defense against pathogens,
which is the host’s innate immune response (Chopy et al., 2011b).
RABV infection activates the innate immune sensors like retinoic
acid inducible gene I (RIG-I) and melanoma differentiation-
associated protein 5 (MDA-5) (Wang et al., 2005; Johnson et al.,
2006; Faul et al., 2010; Chopy et al., 2011a), and triggers a classical
type I interferon (IFN) pathway, to create a chemoattractive
environment and induce inflammatory responses in the infected
cells (Sugiura et al., 2011; Zhao et al., 2011), and eventually an
antiviral environment is set up to trigger an effective immune
response (Wang et al., 2005; Johnson et al., 2006; Faul et al.,
2010). Like most of the viruses, RABV has developed a strategy to
counteract the antiviral effect of the type I IFN response (Chelbi-
Alix et al., 2006; Rieder and Conzelmann, 2009). The N protein
of RABV limits RIG-I signaling (Masatani et al., 2010), whereas
the P protein of RABV inhibits IRF3 phosphorylation (Brzozka
et al., 2005), suppresses STAT1 nuclear translocation (Vidy et al.,
2005; Brzozka et al., 2006), and sequesters an antiviral protein, the
promyelocytic leukemia (PML) protein in the cytoplasm (Blondel
et al., 2010). Moreover, to a certain extent, the RABV can exploit
the innate immune response to develop its immunoevasive
strategy (Chopy et al., 2011b). Once RABV has entered the CNS,
additional innate and adaptive immunemechanisms are required
for attenuated viral clearance. These include the production of
proinflammatory cytokines and chemokines by infected tissues
(Phares et al., 2006), innate and CD4 T cell-mediated alterations
in the blood-brain barrier (BBB) function that facilitate immune
effector infiltration into the CNS, and production of antibodies in
the CNS parenchyma (Roy et al., 2007; Hooper et al., 2011).
Post-exposure treatment of the disease with rabies vaccine
is an effective way to prevent the spread of the virus from a
peripheral site of exposure to the CNS. Infected individuals rarely
develop the immune responses capable of clearing the RABV
from nervous tissue, while a variety of attenuated rabies viruses
can be readily cleared from the CNS tissues in animal models
(Hooper et al., 2011). A wide variety of wild-type and laboratory-
attenuated rabies viral strains are available for comparative
antiviral immune system studies. Although certain mechanisms
have already been implicated in the pathogenesis of the virulent
RABV and clearance of attenuated RABV from the CNS (Wang
et al., 2005; Phares et al., 2006; Roy et al., 2007; Faber et al.,
2009; Hooper et al., 2009; Li et al., 2012; Gnanadurai et al., 2015),
the differences in the host immune responses and pathogeny
during infection by virulent and attenuated RABV strains still
provide a vast scope to conduct precisely planned and more
comprehensive investigations. Advances in the field of high-
throughput RNA sequencing (RNA-Seq) technology has helped
a lot in conducting the transcriptome-level studies to gain deep
insights into the underlying mechanisms of gene regulations
and networks (Yang et al., 2014). In this study, we found that
the attenuated high-egg-passage Flury (HEP-Flury) strain can
enter the brain through intranasal (i.n.) inoculation rather than
intramuscular (i.m.) injection, and cause neurological symptoms
followed by its clearance fromCNS within 40 days after infection.
Here, RNA-Seq has been used for the systematic analysis of global
host transcriptional responses in the CNS of mice infected with
attenuated HEP-Flury and virulent challenge virus standard-11
(CVS-11) strains. The differential regulations, of the genes and
the signaling pathways that might contribute to the pathogenesis
of the virulent rabies virus or the prevention of lethal encephalitis,
were revealed.
MATERIALS AND METHODS
Cells, Viruses, and Animals
Mouse neuroblastoma (NA) cells were maintained in RMPI
1640 medium (Gibco, USA) which contains 10% fetal calf
serum (FBS). CVS-11 and HEP-Flury were propagated in NA
cells. Newcastle disease virus (NDV) vaccine strain LaSota was
purchased from Winsun Pharm Company (Guangzhou, China).
Female BALB/c mice were purchased from Center for Laboratory
Animal Science, Southern Medical University (Guangzhou,
China) and kept at the Laboratory Animal Center of South China
Agricultural University.
Animal Infection and Tissue Collection
The mice were anesthetized with ketamine/xylazine
(100/10mg/kg, intraperitoneally) and given intranasal (i.n.)
doses of 104 focus-forming units (FFU) of either CVS-11 or
HEP-FLury in 50µL of phosphate buffered saline (PBS) and
the mock-infected control mice were treated with PBS. Infected
animals were observed twice per day for 50 days in order to find
any rabies signs and symptoms. Body weight was also monitored
and peripheral blood was obtained at different time intervals.
Serum antibodies against rabies virus were measured using an
ELISA (CitySynbiotics, USA), according to the manufacturer’s
instructions. Antibody titer expressed in EU/ml (equivalent
units per ml) was calculated using the regression curve obtained
from the WHO standard serum dilutions. At the indicated
time points, mice were anesthetized and then perfused by
intracardiac injection of PBS. The brain tissues were removed,
lysed in TRizol R© reagent (Invitrogen, USA) or flash frozen in
liquid nitrogen before being stored at −80◦C, for respective
studies. All the procedures were conducted in accordance
with the Public Health Service Policy on Humane Care and
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Use of Laboratory Animals, under protocols approved by the
Animal Experimentation Ethics Committee (AEEC) of South
China agricultural University (Permit Numbers: 2015B004 and
2015B031).
Whole-Transcriptome Analysis of Mouse
Brain RNA
Total RNAs, isolated from the mouse brains (n = 3)
representing the groups of CVS-11 infected mice at 10 days
post-infection (dpi), HEP-Flury infected mice at 10, 18, 25
dpi and mock-infected mice, were used for transcriptome
analysis. Total RNA was extracted using the RNeasy Midi kit
(Qiagen, Germany). RNA-Seq was performed by Novogene
Bioinformatics Technology Co., Ltd (Beijing, China) following
standard conditions. Sequencing libraries were generated and
processed for high-throughput sequencing on an Illumina Hiseq
2000 platform and 100 bp single-end reads were generated
according to the standard Illumina protocols. Raw data (raw
reads) of fastq format were first processed through in-house perl
scripts. In this step, clean data (clean reads) were obtained by
removing reads containing adapter, reads containing ploy-N and
low quality reads from raw data. All the downstream analyses
were based on the clean data with high quality. Single-end clean
reads were aligned to the mouse reference genome using TopHat
v2.0.9. HTSeq v0.5.4p3 software was used to count the number of
reads mapped against the reference sequence of each gene. The
number of Reads Per Kilobase of exonmodel perMillionmapped
reads (RPKM) is considered as the effective sequencing depth
(Mortazavi et al., 2008). The RPKM of each gene was calculated
based on the length of the gene and reads count mapped to that
particular gene.
Differential expression analyses of the conditions in each
group were performed using the R package DESeq (1.12.0)
(Anders and Huber, 2010). The DESeq package provides
statistical routines for determining differential expression in
digital gene expression data, using a model based on the negative
binomial distribution. The resulting P-values were adjusted
using the Benjamini and Hochberg’s approach for controlling
the False Discovery Rate (FDR). The genes with an adjusted
P < 0.05 and absolute fold change greater than 2.0 were
considered as differentially expressed. Venn diagrams were
created using VENNY 2.0.2 (http://bioinfogp.cnb.csic.es/tools/
venny/index.html). All sequencing data were deposited in NCBI’s
Sequence Read Archive (SRA) database (accession number:
SRP061600).
Gene Ontology (GO) and Pathway Analysis
GO enrichment and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analysis was performed on the sets of
differentially regulated genes using the Database for Annotation,
Visualization, and Integrated Discovery (DAVID) version 6.7
(Huang da et al., 2009). The resulting clustering was then limited
to an enrichment score of >1.00 and a P < 0.05. The FDR for
multiple testing was performed by the Benjamini and Hochberg
method invoked within DAVID.
Quantitative Real-Time RT-PCR (RT-qPCR)
Three mice per group were euthanized at each indicated time
point. The cDNA was prepared from purified RNA using
ReverTra Ace qPCR RT master mix with a genomic DNA
(gDNA) remover kit (Toyobo, Japan). The RT-qPCR assay was
carried out using THUNDERBIRD SYBR qPCR Mix (Toyobo,
Japan) according to the manufacturer’s instructions using specific
primers for the targets. The Primer sequences used for the
amplification of genes are listed in Supplementary Table 1. The
mRNA copy numbers of a particular gene were normalized to the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) using the 2−11CT method (Livak and Schmittgen,
2001).
Western Blotting
The mouse brain tissues were lysed in the lysis buffer (50mM
Tris-HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 1% NP-40)
supplemented with 0.02mM phenylmethanesulfonyl fluoride
(PMSF). After electrophoresis, the separated proteins were
then transferred onto a polyvinylidene difluoride (PVDF)
membrane. Rig-I monoclonal antibody (Cell Signaling
Technology, USA), STAT1 and p-STAT1 polyclonal antibodies
(Bioworld Technology, USA) and horseradish peroxidase
(HRP)-conjugated goat anti-mouse or rabbit IgG (Sigma,
USA) were used, respectively, as the primary and secondary
antibodies at the dilutions recommended by each manufacturer.
The protein bands were detected by BeyoECL plus (Beyotime
Biotech, China).
Statistical Analysis
The significance of differences between groups was evaluated
using one-way analysis of variance (ANOVA) and Tukey’s
multiple-comparison test. The graphs were plotted and analyzed
using Origin 8.0 (OriginLab Corporation, USA).
RESULTS
Different Outcomes of CVS-11 and
HEP-Flury Infections
According to the previous reports and our experimental
evidences, attenuated rabies strain HEP-Flury cannot invade into
the brain to cause rabies via i.m. injection (Takayama-Ito et al.,
2006). In this study, the i.n. route was chosen because it is the
most efficient method of rapidly promoting RABV entry into
the brain while avoiding the injury that induces innate immune
mechanisms that accompany intracranial (i.c.) administration (Li
et al., 2012). The mice infected with CVS-11 developed typical
neurologic signs of rabies, including ataxia and paralysis, and all
died between 10 and 14 days post-infection (dpi) (Figure 1A).
On the other hand, HEP-Flury infected mice showed subtle
clinical signs and loss of body weight (about 15%) between 6
and 24 dpi, but completely recovered in 27 days after infection
(Figure 1B). As shown in Figure 1C, the viral genomic RNA
was readily detected in the brain tissue of HEP-Flury and CVS-
11 infected mice at 4 dpi. The genomic RNA levels of both
groups increased between 4 and 10 dpi, but remained lower
and declined significantly at 18 dpi in the brain tissue of the
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FIGURE 1 | A comparison of the outcomes of pathogenic CVS-11 and attenuated HEP-Flury infections. The groups of BALB/c mice (n = 10) were infected
with 104 FFU of either CVS-11 or HEP-Flury i.n. and PBS mock-infected mice served as the controls. The mice were observed for 50 days, the survival (A) and the
body weight (B) are presented. Three mice per group were euthanized at each indicated time point, and the quantity of genomic RNA in brain tissue samples was
measured by RT-qPCR (C). The anti-rabies antibody (RV-Ab) titers in serum were determined as described in Materials and Methods, and are presented as mean
titers (D). ND, not detected.
HEP-Flury infectedmice. Comparison of the anti-rabies antibody
(RV-Ab) titers at different days after infection revealed that HEP-
Flury infected mice developed RABV-specific immunity at 10 dpi
(Figure 1D), while even low levels of RV-Ab were undetectable
in CVS-11 mice after infection. The HEP-Flury infected mice
produced high RV-Ab titers (>0.6 EU, the threshold level for
protection against rabies) at 18 days after challenge (Figure 1D).
The serum RV-Ab levels continued to increase in the HEP-Flury
infected animals, reaching the level of 8 EU at 30 dpi. These
results revealed that the CVS-11 and HEP-Flury were able to
invade the brain to cause neurological symptoms by the i.n.
route. The CVS-11 infected mice showed more severe clinical
symptoms and higher CVS-11 replication rate, and eventually
died. In the meanwhile, the HEP-Flury viral strains were able
to activate host adaptive immunity better than the CVS-11 viral
strains, and could be eliminated from the CNS.
Global Transcriptome Analysis Revealed
the Immune Regulation of CNS in Rabies
Pathogenesis and Protection
To obtain the comprehensive insight into the host response
mechanisms in the CNS that may influence the outcome of
the infection, we performed comparative whole transcriptome
analysis of the RABV (CVS-11 and HEP-Flury) infected
mouse brain tissues that were collected at 10 days after
the infection. A total of 2233 genes were found to be up-
regulated and 621 genes were down-regulated (a threshold
of ≥2-fold change in expression levels and adjusted P ≤
0.05) in the brain tissue following infection with CVS-11 at
10 days after infection, and 770 genes were up-regulated,
10 gene were down-regulated following infection with HEP-
Flury (Figures 2A,B; also, see details in the Supplementary
Tables 2, 3). The magnitude of the altered genes that were
down-regulated was much lower than up-regulated genes
(Figure 2A). Among the 705 commonly up-regulated genes,
358 genes were at least 2-fold up-regulated in the CVS-11
infected mice compared with the HEP-Flury infected mice,
and are thought to be involved in the innate immune and
inflammatory responses (Figures 2B,C, 3A,B). Another group of
15 genes, mainly involved in antigen processing and presentation
of peptide antigens via MHC class II, were at least 2-
fold up-regulated in the HEP-Flury infected mice compared
with the mice infected with CVS-11 (Figures 2B, 3C). In
addition, many genes showed significant dysregulation only
during CVS-11 infection, including 1528 up-regulated genes
involved in regulation of cell proliferation, response to wounding,
cell adhesion, blood vessel morphogenesis, angiogenesis and
coagulation (Figures 2C,D, 3D–G). Some of these genes might
be involved in the pathological reactions of rabies. In CVS-11
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FIGURE 2 | Differential gene expression profiles in the mouse brain tissue following CVS-11 and HEP-Flury infection at 10 dpi. (A) Graph showing the
number and fold change of up-regulated and down-regulated genes (a threshold of ≥2-fold change in expression levels and adjusted P < 0.05) following virus
infection. (B) A Venn diagram depicting the overlap of differentially expressed genes, and pie chart showing the number of genes that were up-regulated at different
levels. (C) The representative GO terms of the common or unique, differentially regulated genes. (D) The representative KEGG pathways of the common or unique,
differentially regulated genes. For more details, see the Supplementary Tables 2–9.
infected mouse brain tissue, 619 genes with roles in synaptic
transmission and ion transport, mapped to the neuroactive
ligand-receptor interaction, calcium signaling pathway and
Parkinson’s disease, were found to be exclusively down-
regulated (Figures 2C,D, 3H,I). Sixty-five genes uniquely up-
regulated in the brain of HEP-Flury infected mice are mainly
involved in regulation of lymphocyte activation, including
genes encode CD5 antigen, immunoglobulin heavy chain
6, linker for activation of T cells (LAT), Interleukin (IL)-
27 receptor alpha and chemokine (C-X-C motif) receptor
3 (CXCR3) (Supplementary Table 6). More details of Gene
Ontology (GO) enrichment and Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway analysis can be found in
Supplementary Tables 7–9.
In order to further understand the host mechanisms involved
in the prevention of the lethal outcomes, and to obtain
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FIGURE 3 | The representative heat maps showing changes in expression of genes following CVS-11 or HEP-Flury infection. (A) Innate immune
response. (B) Chemotaxis. (C) Adaptive immune response. (D) Cell death. (E) Cell adhesion. (F) Blood vessel morphogenesis or angiogenesis. (G) Wound healing or
coagulation. (H) Ion transport or homeostasis. (I) Transmission of nerve impulse. For more details, see the Supplementary Tables 2–6.
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comprehensive information on the expression kinetics of the
particular host genes in the brain during clearance of HEP-
Flury, comparative transcriptome profiling of the HEP-Flury
infected mouse brain was performed at day 18, when the
most obvious neurological symptoms were observed, and at
day 25, after complete recovery. Overall, most of the genes
with abnormal expression were up-regulated, only a few
genes were down-regulated (Figures 4A,B). The largest amount
of up-regulated genes emerged at 18 dpi, and might be
associated with the obvious clinical symptoms. According to the
temporal expression pattern at 10, 18, 25 dpi, we subdivided
altered genes into 4 distinct clusters (Figure 4C). Cluster 1,
consisted of the genes that showed the highest level at 10
dpi, and contained 305 genes involved in different cellular
processes including antigen processing and presentation, innate
immune response and inflammatory response (Figure 4D).
Cluster 2, in which gene expression was increased until 18
dpi, had 751 members, including genes implicated in leukocyte
activation and inflammatory response (Figure 4D). Cluster
3 consisted of 31 genes that were up-regulated consistently
from 10 to 25 dpi, including 4 immunoglobulin genes.
Cluster 4, consisted of 21 genes that were expressed at the
highest levels in mock-infected mice, including genes encode
hemoglobin beta chain, gastrokine 3 and gap junction gamma-2
protein.
HEP-Flury Infection Induced the Early
Expression of Genes Associated with
Rig-I-Like Receptor Signaling Pathway and
Activated the Adaptive Immunity
Completely
In order to analyze the dynamic expression of important
immune-related genes, we used RT-qPCR to compare the
FIGURE 4 | Differential gene expression profiles in the mouse brain tissue following HEP-Flury infection at 10 dpi, 18 dpi and 25 dpi. (A) The number of
differentially expressed genes in HEP-Flury infected mice at 10, 18, and 25 dpi. (B) Venn diagrams showing the overlap of differentially expressed genes in the infected
mouse brains. (C) Graphs showing 4 distinct clusters of the differentially expressed genes. (D) The representative GO terms of the altered genes in the 4 distinct
clusters. For more details, see the Supplementary Tables 3–5, 10–12.
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expression levels of several innate and adaptive immune effectors
in the mouse brain tissues following CVS-11 or HEP-Flury
challenge at 4, 7, and 10 dpi. The RT-qPCR analysis revealed
that the RIG-I, MDA5 and their regulators such as RING finger
protein 125 (RNF125), Interferon-stimulated gene 15 (ISG15),
DExH (Asp-Glu-X-His) box polypeptide 58 (Dhx58, also known
as LGP2) were up-regulated following CVS-11 and HEP-Flury
infections (Figure 5A). Most of these genes were up-regulated
more rapidly and strongly in the HEP-Flury infection than the
CVS-11 at 4 dpi besides RNF125.Whereas, all of these genes were
largely expressed in both groups after 7 dpi and overexpressed
more intensively following CVS-11 infection. Interferon (IFN)
genes IFN-α4, IFN-β, IFN regulatory factors (IRF-3, IRF-7,
and IRF-9), and IFN-induced genes were all significantly up-
regulated in CVS-11 or HEP-Flury infected mouse brains after
7 dpi, and more intensively in CVS-11 infected mouse brains
(Figure 5B). Notably, the IFN-β and IRF-7 were up-regulated
earlier at day 4 after HEP-Flury infection but not in CVS-11
infection, and IFN-γ was significantly elevated in the HEP-Flury
infected mouse brains than the CVS-11 infected mouse brains
after 10 dpi (Figure 5B). The proinflammatory chemokines in
both the families C-C and C-X-C, including CCL2 (MCP), CCL3
(MIP-1α), CCL4 (MIP-1β), CCL7 (MCP-3), CXCL1 (MIP-2α),
CXCL9 (MIG), CXCL10 (IP-10), and CXCL11 (IP-9) were all
up-regulated with both CVS-11 and HEP-Flury infections and
reached peak levels at 10 dpi, some even increased more than
1000-fold (Figures 5C,D). Among them, CXCL9, CXCL10, and
CXCL11 were elevated more significantly following HEP-Flury
infection at 4 dpi than CVS-11 infection. The CXCR3, a receptor
of CXCL9, CXCL10, and CXCL 11, was elevated only in the brains
of theHEP-Flury infectedmice at 10 dpi (Figure 5D). ThemRNA
levels specific for c-Jun, tumor necrosis factor alpha (TNF-α)
and interleukin-6 (IL-6) were increased more significantly in
the CVS-11 infected mouse brains than the HEP-Flury infected
mouse brains after 7 dpi (Figure 5C). Furthermore, the western
blot analysis with antibodies against RIG-I, STAT-1, and p-STAT-
1 showed that they were all gradually up-regulated in response
to infection with both viruses, indicating that either CVS-11 or
HEP-Flury can engage RIG-I and IFN-α/β during the infection,
resulting in the innate immune signaling (Figure 5E). A intense
band of STAT-1 and a weak band of RIG-I appeared earlier at
day 4 after the HEP-Flury infection, which indicated that the
RIG-I-like receptor signaling pathway was activated quickly by
HEP-Flury infection, this result was consistent with the results of
RT-qPCR.
Corresponding to the above results that IFN-γ was elevated at
higher levels in the HEP-Flury infected mouse brains, the IFN-
γ-induced MHC class II transactivator gene (CIITA), MHC class
II associated invariant chain (Ii; CD74) and MHC class II were
all elevated more significantly following the HEP-Flury infection
at 10 dpi than the CVS-11 infection (Figure 6). On the other
hand, expression levels of the MHC class I were higher following
CVS-11 infection at either 7 or 10 dpi. The mRNAs specific for
lymphocyte surface markers, including CD19, CD3, CD4, CD8,
were up-regulated more significantly in response to the infection
with HEP-Flury at 10 dpi (Figure 6). Icos, which is essential
for the effective T-helper-cell responses, was more significantly
increased after the HEP-Flury infection at 10 dpi. The κ light-
chain mRNA, indicative of antibody production, was elevated to
higher levels in the HEP-Flury infected mice at 10 dpi.
The Innate Immunity Pre-activated by
HEP-Flury or NDV Infection Can Effectively
Prevent the CVS-11 from Invading in the
CNS
The above results proved that the HEP-Flury infection can
activate the innate immunity earlier and trigger the adaptive
immune responses more completely as compared to the CVS-
11 infection. To further investigate whether the intermodulation
or crosstalk existed in the immune responses following CVS-
11 and HEP-Flury infections, we infected mice i.n. with 104
FFU of HEP-Flury in advance and then challenged the mice
with lethal doses of CVS-11 i.n. at 0, 2, 4, 8 days after the
HEP-Flury infection. Unexpectedly, the mice challenged by CVS-
11 at 4 and 8 days post HEP-Flury infection showed 100%
survival (Figure 7A). Those challenged at 0 and 2 days post
HEP-Flury infection achieved 30 and 60% survival, respectively.
Only HEP-Flury was detected in all brains of survived mice. A
parallel group of CVS-11 infected mice at 2 days after HEP-
Flury infection was set up and brains were removed at 8 days
post CVS-11 infection. Detection with the specific primers for
HEP-Flury or CVS-11 showed 100% HEP-Flury-positive and
50% CVS-11-positive, indicating that once CVS-11 enters the
brain, mice will eventually die even if infected with HEP-Flury in
advance. Based on our findings, we speculate that the HEP-Flury
infection may initiate some immune responses to prevent CVS-
11 entry into the brain but not clearance from CNS. In order to
distinguish which immune responses prevent the development
of rabies, the mice were infected i.n. with HEP-Flury and NDV
vaccine strain, treated i.n. with inactivated HEP-Flury and Poly
(I: C), or injected i.m. with HEP-Flury at 4 days before challenge
with CVS-11, all mice that survived belonged to the HEP-Flury
and NDV pre-infected groups but not others (Figure 7B). The
survival rate of the NDV infected group was 60%, indicating that
the innate immunity plays a critical role in preventing CVS-11
from invading or progressing in the CNS. RT-qPCR was used
to compare the expression of several innate immune effectors,
that were up-regulated earlier during HEP-Flury infection in the
previous experiments, in the mouse brain tissues of different
groups (Figure 7C). The results revealed that only CXCL10 was
specifically and significantly elevated in the HEP-Flury or NDV
pre-infected mice (Figure 7C), suggesting that CXCL10 may
play a role in blockage of early CVS-11 infection of the CNS.
More extensive studies will be required to identify the critical
innate immune factors for protection against the CNS invasion
of RABV.
DISCUSSION
The clinical outcome of viral infections depends on the balance
between viral replication and the host immune response. The
uncontrolled replication of virus in the CNS leads to the
disease and ultimately death. In this study, during the process
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FIGURE 5 | RT-qPCR and western blot analyses of the temporal alterations of genes associated with RIG-I-like receptor signaling pathway. RT-qPCR
analyses of the genes involved in the innate immunity (A,B) or chemotaxis (C,D), and western blot detection of RIG-I, STAT, and p-STAT (E). The asterisks indicate
significant differences in the copy numbers between different RABV infections at same time points determined by one-way ANOVA and Tukey’s multiple-comparison
test. ***,**, and * represent P-values of less than 0.001, 0.01, and 0.05, respectively.
Frontiers in Microbiology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 751
Zhang et al. Host Responses to Distinct RABVs Infection
FIGURE 6 | RT-qPCR analyses of the temporal alterations of genes involved in the adaptive immunity in the mouse brains with CVS-11 or HEP-Flury
infections. The asterisks indicate significant differences in the copy numbers between different RABV infections at same time points determined by one-way ANOVA
and Tukey’s multiple-comparison test. ** and * represent P-values of less than 0.01 and 0.05, respectively.
of infection, the attenuated HEP-Flury replicated more slowly,
triggered the innate immunity earlier and achieved the adaptive
immunity more completely than the virulent CVS-11 strain,
leading to the subtle clinically observable signs and clearance
from the CNS. Our results showed that the type I IFN response
is continuously triggered in either CVS-11 or HEP-Flury infected
mice, although RABV dampens type I IFN signaling by inhibiting
IRF3 phosphorylation and STAT1 translocation (Brzozka et al.,
2005, 2006; Vidy et al., 2005). The RABV viral signature
RNA, such as the 5′-triphosphate RNAs, are detected by RIG-
I protein, leading to RIG-I activation and interaction with
the mitochondrial protein IFN-β promoter stimulator-1 (IPS-1)
(Faul et al., 2010). Indeed, many genes that mapped to the RIG-
I-like receptor signaling pathway were remarkably up-regulated
in both CVS-11 and HEP-Flury infections (Figure 2D). The
only differences were that RIG-I, MDA5, ISG15 were elevated
earlier in the HEP-Flury infected mouse brains, whereas LGP2
and RNF125, two negative regulators of RIG-I/MDA5 signaling
were increased at higher levels in the CVS-11 infected mouse
brains at a later stage (Figure 5A). Regardless of the differences,
a large number of IFN effector genes, IFN stimulated genes,
inflammatory cytokines and chemokines were generally up-
regulated in both infections. The 5′-triphosphate viral dsRNA
and leader RNAs of RABV are the main pathogen-associated
molecular patterns recognized by RIG-I/MDA-5 (Faul et al.,
2010; Jensen and Thomsen, 2012). Yang et al. have found that a
reduced level of de novo-synthesized leader RNA was generated
in dendritic cells infected with the wild-type RABV compared to
the laboratory-attenuated RABV (Yang et al., 2015). Therefore,
we speculate that the level of de novo-synthesized leader RNA
generated in the CNS infected by CVS-11 may be lower than
in the HEP-Flury-infected CNS at the early stage, and it would
be gradually elevated along with the increase in the viral load.
In addition to the RIG-I-like receptor signaling pathway, HEP-
Flury and especially CVS-11 can also stimulate the expression of
genes encoding the TLRs, such as TLR-1, TLR-2, TLR-3, TLR-4,
TLR-6, TLR-7, TLR-9, TLR-12, and TLR-13. It has been reported
previously that the viral surface glycoproteins can activate TLRs
(Li et al., 2011), suggesting the involvement of some other
components of the RABV or stress proteins in the activation
of TLR pathways and IFN-regulatory factors besides the viral
genomic RNA. Previous studies have shown that the animals with
RABV infections, pretreated or simultaneously treated with IFN
or IFN inducers, could control RABV infection (Postic and Fenje,
1971; Marcovistz et al., 1987). In our present study, intranasal
inoculation with the HEP-Flury or NDV promotes survival
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FIGURE 7 | Intranasal inoculation with the HEP-Flury or NDV, promotes survival in CVS-11 challenged mice. (A) The groups of 10 adult mice infected i.n.
with 104 FFU of HEP-Flury in advance and then infected with 104 FFU of CVS-11 i.n. at 0, 2, 4, 8 days post HEP-Flury infection. (B) The groups of 10 adult mice
pretreated respectively with 104 FFU of HEP-Flury (i.n. inoculation), HEP-Flury (i.m. injection), β-propiolactone-inactivated HEP-Flury (i.n. inoculation), 107 EID50 NDV
vaccine strain LaSota (i.n. inoculation) and 100µg poly (I:C) (i.n. inoculation, once a day), and then infected with 104 FFU of CVS-11 i.n. at 4 days after pretreatment.
The mice were observed for 50 days. (C) The RT-qPCR analysis of the alterations of several innate immunity genes in the mouse brain tissues of different groups.
***,**, and * represent P-values of less than 0.001, 0.01, and 0.05, respectively.
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in CVS-11 challenged mice. Similar to RABV, NDV is also
a non-segmented negative-stranded RNA virus and generates
5′-triphosphate viral RNA, which can be recognized by RIG-
I/MDA-5 (Hornung et al., 2006; Sun et al., 2013; Oh et al.,
2016), and efficiently triggers the production of IFN. Our results
indicate that the innate immunity activated by certain RNA virus
infections can effectively prevent virulent RABV from spreading
to the CNS causing fatal encephalitis before the adaptive
immunity is induced. Although the mechanisms and conditions
for the innate immune protection need further investigations,
additional treatment with suitable innate immunity activators
might play a positive role in prophylaxis of rabies after exposure,
especially in the higher-risk exposures like bites on the face.
Many inflammatory cytokines and chemokines were highly
up-regulated in the HEP-Flury or (particularly) in the CVS-11
infected mice. It is possible that the interactions among neurons,
astrocytes, microglia, and infiltrating T cells are responsible for
the up-regulation of so many chemokines in RABV infections
(Wang et al., 2005). Although the chemokines have direct
antiviral activities in the recruitment of inflammatory cells to
the site of infection to kill the virus or virus-infected cells
(Melchjorsen et al., 2003), overexpression of CCL5 (RANTES)
or CXCL10 (IP-10) increased RABV pathogenicity by causing
neurological diseases, which is due to the excessive infiltration
and accumulation of the inflammatory cells in the CNS (Zhao
et al., 2009). However, recombinant RABVs expressing CCL3,
CCL22 (MDC), as well as GM-CSF can further attenuate RABV
(Zhao et al., 2010; Niu et al., 2011). Our results showed that the
majority of chemokines and receptors were up-regulated more
strongly in the CVS-11 infection than the HEP-Flury at a later
stage, besides CCL22, CXCR3, CXCR6, and CCR7 (Figure 3,
Supplementary Tables 2, 3). On the other hand, the expression
of CXCL10 was induced earlier following HEP-Flury or NDV
infection, suggesting its positive role in protection against initial
infection of RABV. In West Nile virus (WNV) infection, it is
neuronal CXCL10 that directs CD8+ T Cell recruitment and
control of WNV encephalitis (Klein et al., 2005). Therefore,
the roles of chemokines in rabies pathogenesis and protection
deserve further study.
It has been reported that the infection with wild-type (wt)
SHBRV does not induce MHC class II expression in the
neurovasculature (Roy et al., 2007; Hooper et al., 2011). A recent
study showed that the MHC class II was not up-regulated in
dendritic cells (DCs) after infection with the wt RABV in vitro,
which demonstrates that the wt RABV evades DC-mediated
immune activation (Yang et al., 2015). In this study, MHC class
II positive regulators IFN-γ, transactivator CIITA and MHC
class II-associated invariant chain (CD74), which is a type II
integral membrane protein essential for proper MHC class II
folding in the endoplasmic reticulum (Matza et al., 2003), were
suppressed to some extent at 10 days after the CVS-11 infection
compared with the HEP-Flury infection. In addition, the MHC
class II negative regulators including TGF-β and IFN-β (Ting and
Trowsdale, 2002) were elevated at higher levels following CVS-
11 infection at 10 dpi. In accordance with these observations,
the expression of MHC class II was impaired in the mouse
brain tissues infected with CVS-11, while their expression was
induced in theHEP-Flury infected brain tissues. The presentation
of the peptides to T cells by MHC class II molecules is of
critical importance in specific recognition to a pathogen by
the immune system and the expression levels of MHC class II
directly influence the T lymphocyte activation (Li et al., 2009).
In addition, the less elevated mRNA of immunoglobulin κ light
chain and failure to produce the protective antibodies in CVS-
11 infected mice suggest that the virulent RABV may impair the
MHC class II antigen presentation and activation of T cells to
inhibit the adaptive immune responses. It has been reported that
some viruses have evolved elaborate strategies to disrupt MHC
class II-mediated T cell responses by inhibiting MHC class II
expression (Moutaftsi et al., 2002; Li et al., 2009). Our findings
provide a clue to elucidate a strategy to inhibit the adaptive
immunity by the virulent RABVs.
Histological studies have shown that the CNS of RABV
infected mice was infiltrated by CD4+ and CD8+ T cells, with
CD8+ T cells outnumbering CD4+ T cells from day 10 onwards
(Galelli et al., 2000). Among the T cell population, the protection
of RABV is conferred exclusively by CD4+ T cells because fatal
encephalopathogeny develops only after the depletion of the
CD4+ and not the CD8+ T cells (Galelli et al., 2000; Hooper et al.,
2011). Noticeably, the CD4 mRNA was increased in the HEP-
Flury infectedmouse brains but was down-regulated in the brains
of CVS-11 infected mice, and CD8 mRNA was up-regulated
more significantly in response to the infection with HEP-Flury
(Figures 3, 6). It has been reported that the pathogenic RABV
strain associated with the silver-haired bat (SHBRV) fails to
open the BBB and deliver immune effectors, including IFN-
γ+ CD4 T cells, to CNS and leads to a lethal outcome (Roy
et al., 2007). Furthermore, Chai et al found that the enhancement
of BBB permeability in mice infected with attenuated RABV
is associated with the reduction of tight junction (TJ) protein,
such as claudin-5, occludin, and zonula occludens-1 (Chai et al.,
2014). During the later stage of CVS-11 infection, the exclusively
up-regulation of claudin-5, 15, and 23 (Figure 3) and down-
regulation of adenosine A2a receptor, which has been indentified
as a critical mediator of BBB permeability (Carman et al., 2011),
implies an inability to enhance blood-brain barrier permeability
and deliver immune effectors, especially the CD4+ T cells,
to the CNS tissues in the CVS-11 infected mice. In addition,
the immunosubversive molecules such as B7-H1 and HLA-G,
which trigger death signaling in activated T cells expressing the
corresponding ligands (Lafon, 2011), were up-regulated more
significantly in CVS-11 infected mouse brains suggests that
CVS-11 triggers the worse conditions for T cell survival. The
chemokines CXCL9, CXCL10, and CXCL11 are structurally and
functionally related IFN-γ-inducible proteins, each bind to the
receptor CXCR3 expressed on activated CD4+ T cells and play a
function in governing themigration of lymphocytes into the CNS
(Muller et al., 2010). Previous studies have indicated that CXCR3
mediates CNS accumulation of antibody secreting cells during
neurotropic coronavirus-induced encephalomyelitis (Marques
et al., 2011). Here, CXCR3, up-regulated specifically in the mouse
brain tissues infected with HEP-Flury, together with the higher
expression level of INF-γ and MHC class II, help sketch out a
hypothesis that cross talks between INF-γ, chemokines, MHC
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class II antigen presentation and CD4+ T cell signaling pathways
play a pivotal role in the enhancement of BBB permeability and
clearance of attenuated RABV from the CNS (Figure 8).
This is the first report that demonstrates the pathogenic
RABV infection can induce the expression of genes, which
encode extracellular matrix (ECM) proteins and play roles in
blood vessel morphogenesis and angiogenesis. Angiogenesis and
inflammation are frequently coupled in pathological situations
such as arthritis, atherosclerosis and diabetes (Arroyo and Iruela-
Arispe, 2010). The inflammatory response increases capillary
permeability and induces endothelial activation, which, when
persistent, results in capillary sprouting (Carmeliet, 2000; Arroyo
and Iruela-Arispe, 2010). Inflammation-induced angiogenesis
and the subsequent remodeling steps are largely mediated by
FIGURE 8 | Schematic overview of the differential expression of key genes involved in the immune responses to HEP-Flury and CVS-11 infection in the
CNS. Genes, commonly up-regulated in HEP-Flury and CVS-11 infected brains are marked in red, uniquely up- and down-regulated in CVS-11 infected brains are
marked in orange and green, respectively. Genes, up-regulated more significantly in response to the infection with HEP-Flury are marked in pink, uniquely
up-regulated in HEP-Flury infected brains are marked in blue. +, indicates activation. −, indicates inhibition. Figure was produced using the elements of Servier
Medical Art (http://www.servier.com/Powerpoint-image-bank).
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ECM proteins and proteases (Arroyo and Iruela-Arispe, 2010).
The delicate relationship between inflammation and blood vessel
morphogenesis in the CNS following RABV infection deserves
comprehensive investigations. Electrophysiological changes and
dysfunction of ion channels have been observed in the human
rabies patients (Iwata et al., 1999; Fu and Jackson, 2005;
Mitrabhakdi et al., 2005). These alterations in neurophysiology
might be due to the malfunction in neurotransmission. Many of
the genes involved in synaptic transmission and ion transport
are uniquely down-regulated in CVS-11 infection, some of them
have been identified in previous proteomic analyses of RABV
infection (Dhingra et al., 2007; Zandi et al., 2009). Alpha-2
adrenoreceptor was significantly decreased in RABV infection,
which could possibly contribute to clinical features of rabies,
including hyperexcitability and aggressive behavior (Iwata et al.,
2000). 5-Hydroxytryptamine receptor (5-HT) was also found to
be significantly decreased in the later stages of RABV infection
(Akaike et al., 1995). In addition to adrenoceptor and 5-HT,
adenosine A2a receptor, alpha-adrenergic receptor, oxytocin
receptor, dopamine receptor 2, glutamate receptor and ryanodine
receptor 1 were found to be down-regulated in CVS-11 infection.
These alterations might lead to the degenerative changes and
dysfunction of neuronal processes. On the other hand, two
neural activity related genes, neuronal PAS domain protein
4 (Npas4) and activity regulated cytoskeletal (Arc)-associated
protein, were progressively up-regulated in HEP-Flury infected
mouse brains and sustained to 25 dpi. The expression of Npas4
was inhibited in the CVS-11 infected brains. It is a transcription
factor, highly expressed in the brain, and regulates the formation
and maintenance of the inhibitory synapses as well as excitatory-
inhibitory balance within the neural circuits (Spiegel et al., 2014).
The Arc is required for homeostatic synaptic scaling of AMPA
receptors and consolidation of the synaptic plasticity (Bai et al.,
2011). They could possibly play an important role in the neural
recovery from the RABV infections.
Altogether, our results provide a broader view of the interplay
between the RABV and the host. Virulent CVS-11 infection
causes extensive inflammation, immune responses and nervous
system dysfunction and induces many more altered genes
than attenuated HEP-Flury infection. Once the infection is
established, HEP-Flury, but not the CVS-11, can be effectively
suppressed by innate immunity and cleared from the CNS prior
to the induction of adaptive immunity. In the CVS-11 infected
mouse brains, the expression of MHC class II and activation
of CD4+ T cells were impaired, resulting in the failure to
stimulate the VNAs and revealing a mechanism of immune
suppression of the pathogenic RABVs. Genomic transcriptional
analysis is an effective technique but not enough on its own to
define the critical causes and effects of virus-host interactions.
Extensive studies in different regulatory levels, using different
RABV strains and inoculation routes are warranted in future
investigations.
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